Simian foamy virus infection by whole-blood transfer in rhesus macaques: Potential for transfusion transmission in humans

Transfusion

Volumn 46, Issue 8, 2006, Pages 1352-1359

  Khan, Arifa S ^a,b   Kumar, Dhanya ^a  

^a CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^b Building 29B ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD ANALYSIS; BLOOD TRANSFUSION; CELL CULTURE; CONTROLLED STUDY; IMMUNOASSAY; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; POLYMERASE CHAIN REACTION; RETROVIRUS; SIMIAN FOAMY VIRUS; SIMIAN FOAMY VIRUS INFECTION; VIRUS INFECTION; VIRUS ISOLATION; VIRUS STRAIN; VIRUS TRANSMISSION;

ANIMALS; ANIMALS, ZOO; ANTIBODIES, VIRAL; BLOOD TRANSFUSION; CELLS, CULTURED; COCULTURE TECHNIQUES; DISEASE MODELS, ANIMAL; HUMANS; LEUKOCYTES, MONONUCLEAR; MACACA MULATTA; OCCUPATIONAL EXPOSURE; RETROVIRIDAE INFECTIONS; RNA, VIRAL; SPUMAVIRUS; ZOONOSES;

EID: 33746381930     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2006.00862.x     Document Type: Article

References (34)

1. Apetrei C, Marx PA. Simian retroviral infections in human beings. Lancet 2004;364:137-8;author reply 139-40.
2. Aguzzi A. The foamy virus family: molecular biology, epidemiology and neuropathology. Biochim Biophys Acta 1993;1155:1-24.
3. Meiering CD, Linial ML. Historical perspective of foamy virus epidemiology and infection. Clin Microbiol Rev 2001;14:165-76.
4. Mergia A, Leung NJ, Blackwell J. Cell tropism of the simian foamy virus type 1 (SFV-1). J Med Primatol 1996;25:2-7.
5. Achong BG, Mansell PW, Epstein MA, Clifford P. An unusual virus in cultures from a human nasopharyngeal carcinoma. J Natl Cancer Inst 1971;46:299-307.
6. Schweizer M, Falcone V, Gange J, et al. Simian foamy virus isolated from an accidentally infected human individual. J Virol 1997;71:4821-4.
7. Schweizer M, Turek R, Hahn H, et al. Markers of foamy virus infections in monkeys, apes, and accidentally infected humans: appropriate testing fails to confirm suspected foamy virus prevalence in humans. AIDS Res Hum Retroviruses 1995;11:161-70.
8. Heneine W, Switzer WM, Sandstrom P, et al. Identification of a human population infected with simian foamy viruses. Nat Med 1998;4:403-7.
9. Brooks JI, Rud EW, Pilon RG, et al. Cross-species retroviral transmission from macaques to human beings. Lancet 2002;360:387-8.
10. Switzer WM, Bhullar V, Shanmugam V, et al. Frequent simian foamy virus infection in persons occupationally exposed to nonhuman primates. J Virol 2004;78:2780-9.
11. Heneine W, Schweizer M, Sandstrom P, Folks T. Human infection with foamy viruses. Curr Top Microbiol Immunol 2003;277:181-96.
12. Sandstrom PA, Phan KO, Switzer WM, et al. Simian foamy virus infection among zoo keepers. Lancet 2000;355:551-2.
13. Wolfe ND, Switzer WM, Carr JK, et al. Naturally acquired simian retrovirus infections in central African hunters. Lancet 2004;363:932-7.
14. von Laer D, Neumann-Haefelin D, Heeney JL, Schweizer M. Lymphocytes are the major reservoir for foamy viruses in peripheral blood. Virology 1996;221:240-4.
15. Callahan ME, Switzer WM, Matthews AL, et al. Persistent zoonotic infection of a human with simian foamy virus in the absence of an intact orf-2 accessory gene. J Virol 1999;73:9619-24.
16. Boneva RS, Grindon AJ, Orton SL, et al. Simian foamy virus infection in a blood donor. Transfusion 2002;42:886-91.
17. Delwart EL, Kalmin ND, Jones TS, et al. First report of human immunodeficiency virus transmission via an RNA-screened blood donation. Vox Sang 2004;86:171-7.
18. Donegan E, Lee H, Operskalski E, et al. Transfusion transmission of retroviruses: human T-lymphotropic virus types I and II compared with human immunodeficiency virus type 1. Transfusion 1994;34:478-83.
19. Heberling RL, Kalter SS. Rapid dot-immunobinding asay on nitrocellulose for viral antibodies. J Clin Microbiol 1986;23:109-13.
20. Institute for Laboratory Animal Research NRC. Guide for the care and use of laboratory animals. Washington (DC): National Academy Press; 1996.
21. Khan AS, Sears JF, Muller J, et al. Sensitive assays for isolation and detection of simian foamy retroviruses. J Clin Microbiol 1999;37:2678-86.
22. Sears JF, Khan AS. Single-tube fluorescent product-enhanced reverse transcriptase assay with Ampliwax (STF-PERT) for retrovirus quantitation. J Virol Methods 2003;108:139-42.
23. Karber G. A contribution to the collective treatment of a pharmacological experimental series. Arch Exp Pathol Pharmakol 1931;162:480-3.
24. Hussain AI, Shanmugam V, Bhullar VB, et al. Screening for simian foamy virus infection by using a combined antigen Western blot assay: evidence for a wide distribution among Old World primates and identification of four new divergent viruses. Virology 2003;309:248-57.
25. Shibata R, Igarashi T, Haigwood N, et al. Neutralizing antibody directed against the HIV-1 envelope glycoprotein can completely block HIV-1/SIV chimeric virus infections of macaque monkeys. Nat Med 1999;5:204-10.
26. Nishimura Y, Igarashi T, Haigwood N, et al. Determination of a statistically valid neutralization titer in plasma that confers protection against simian-human immunodeficiency virus challenge following passive transfer of high-titered neutralizing antibodies. J Virol 2002;76:2123-30.
27. Campbell TB, Schneider K, Wrin T, et al. Relationship between in vitro human immunodeficiency virus type 1 replication rate and virus load in plasma. J Virol 2003;77:12105-12.
28. Hartung S, Boller K, Cichutek K, et al. Quantitation of a lentivirus in its natural host: simian immunodeficiency virus in African green monkeys. J Virol 1992;66:2143-9.
29. Ho DD, Moudgil T, Alam M. Quantitation of human immunodeficiency virus type 1 in the blood of infected persons. N Engl J Med 1989;321:1621-5.
30. Barbour JD, Grant RM. The role of viral fitness in HIV pathogenesis. Curr HIV/AIDS Rep 2005;2:29-34.
31. Karpas A. Human retroviruses in leukaemia and AIDS: reflections on their discovery, biology and epidemiology. Biol Rev 2004;79:911-33.
32. Korber B, Muldoon M, Theiler J, et al. Timing the ancestor of the HIV-1 pandemic strains. Science 2000;288:1789-96.
33. Takebe Y, Kusagawa S, Motomura K. Molecular epidemiology of HIV: tracking AIDS pandemic. Pediatrics Int 2004;46:236-44.
34. Linial M. Why aren't foamy viruses pathogenic? Trends Microbiol 2000;8:284-9.